HCPCS Level II
J0696
Injection, ceftriaxone sodium, per 250 mg
Codes near J0696
These sit next to J0696 in the CMS Level II file. All J codes
- J0691Injection, lefamulin, 1 mg
- J0692Injection, cefepime hydrochloride, 500 mg
- J0693Injection, cefiderocol, 5 mg
- J0694Injection, cefoxitin sodium, 1 gm
- J0695Injection, ceftolozane 50 mg and tazobactam 25 mg
- J0697Injection, sterile cefuroxime sodium, per 750 mg
- J0698Injection, cefotaxime sodium, per gm
- J0699Injection, cefiderocol, 10 mg
- J0701Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
- J0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00143-9678-01 | Ceftriaxone | Hikma Pharmaceuticals USA Inc. | 40 |
| 00143-9856-25 | Ceftriaxone | Hikma Pharmaceuticals USA Inc. | 200 |
| 00143-9857-25 | Ceftriaxone | Hikma Pharmaceuticals USA Inc. | 100 |
| 00143-9858-25 | Ceftriaxone | Hikma Pharmaceuticals USA Inc. | 50 |
| 00143-9859-25 | Ceftriaxone | Hikma Pharmaceuticals USA Inc. | 25 |
| 00264-3153-11 | Ceftriaxone in D5W | B. Braun Medical Inc. | 96 |
| 00264-3155-11 | Ceftriaxone in D5W | B. Braun Medical Inc. | 192 |
| 00338-5002-41 | Ceftriaxone in D5W | Baxter Healthcare Corporation | 96 |
| 00338-5003-41 | Ceftriaxone in D5W | Baxter Healthcare Corporation | 192 |
| 00409-7332-01 | Ceftriaxone | Pfizer Inc | 40 |
| 00409-7332-20 | Ceftriaxone | Pfizer Inc | 40 |
| 00409-7333-04 | Ceftriaxone | Pfizer Inc | 40 |
| 00409-7333-49 | Ceftriaxone | Pfizer Inc | 40 |
| 00409-7334-10 | Ceftriaxone | Pfizer Inc | 40 |
| 00409-7334-20 | Ceftriaxone | Pfizer Inc | 40 |
| 00409-7335-03 | Ceftriaxone | Pfizer Inc | 80 |
| 00409-7335-20 | Ceftriaxone | Pfizer Inc | 80 |
| 00409-7336-04 | Ceftriaxone | Pfizer Inc | 80 |
| 00409-7337-01 | Ceftriaxone | Pfizer Inc | 10 |
| 00409-7337-20 | Ceftriaxone | Pfizer Inc | 10 |
| 00409-7338-01 | Ceftriaxone | Pfizer Inc | 20 |
| 00409-7338-20 | Ceftriaxone | Pfizer Inc | 20 |
| 00781-3206-85 | Ceftriaxone | Sandoz Inc. | 1 |
| 00781-3206-95 | Ceftriaxone | Sandoz Inc. | 10 |
| 00781-3207-85 | Ceftriaxone | Sandoz Inc. | 2 |
| 00781-3207-95 | Ceftriaxone | Sandoz Inc. | 20 |
| 00781-3208-85 | Ceftriaxone | Sandoz Inc. | 4 |
| 00781-3208-95 | Ceftriaxone | Sandoz Inc. | 40 |
| 00781-3209-95 | Ceftriaxone | Sandoz Inc. | 80 |
| 00781-3210-46 | Ceftriaxone | Sandoz Inc. | 40 |
| 25021-0105-10 | Ceftriaxone | Sagent Pharmaceuticals | 50 |
| 25021-0105-66 | Ceftriaxone | Sagent Pharmaceuticals | 50 |
| 25021-0106-10 | Ceftriaxone | Sagent Pharmaceuticals | 100 |
| 25021-0106-67 | Ceftriaxone | Sagent Pharmaceuticals | 100 |
| 25021-0107-20 | Ceftriaxone | Sagent Pharmaceuticals | 200 |
| 25021-0107-68 | Ceftriaxone | Sagent Pharmaceuticals | 200 |
| 25021-0108-69 | Ceftriaxone | Sagent Pharmaceuticals | 40 |
| 25021-0108-99 | Ceftriaxone | Sagent Pharmaceuticals | 40 |
| 44567-0700-25 | Ceftriaxone | WG Critical Care, LLC | 50 |
| 44567-0701-25 | Ceftriaxone | WG Critical Care, LLC | 100 |
| 44567-0701-95 | Ceftriaxone | WG Critical Care, LLC | 100 |
| 44567-0702-25 | Ceftriaxone | WG Critical Care, LLC | 200 |
| 44567-0702-95 | Ceftriaxone | WG Critical Care, LLC | 200 |
| 44567-0703-01 | Ceftriaxone | WG Critical Care, LLC | 40 |
| 50090-0944-00 | Ceftriaxone | A-S Medication Solutions | 20 |
| 50090-0945-00 | Ceftriaxone | A-S Medication Solutions | 40 |
| 50090-1875-00 | Ceftriaxone | A-S Medication Solutions | 10 |
| 50090-2444-00 | Ceftriaxone | A-S Medication Solutions | 1 |
| 50090-3810-01 | Ceftriaxone | A-S Medication Solutions | 40 |
| 50090-3838-00 | Ceftriaxone | A-S Medication Solutions | 2 |
| 50090-4689-00 | Ceftriaxone | A-S Medication Solutions | 10 |
| 60505-6148-04 | Ceftriaxone | Apotex Corp | 40 |
| 60505-6149-04 | Ceftriaxone | Apotex Corp | 80 |
| 60505-6150-05 | Ceftriaxone | Apotex Corp | 40 |
| 60505-6151-01 | Ceftriaxone | Apotex Corp | 10 |
| 60505-6151-04 | Ceftriaxone | Apotex Corp | 1 |
| 60505-6152-01 | Ceftriaxone | Apotex Corp | 20 |
| 60505-6152-04 | Ceftriaxone | Apotex Corp | 2 |
| 63323-0346-10 | Ceftriaxone | FreseniUS Kabi USA, LLC | 100 |
| 72572-0061-25 | Ceftriaxone | Civica, Inc. | 100 |
| 72572-0062-25 | Ceftriaxone | Civica, Inc. | 200 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.